NSG 6320 AGNP BOARD EXAM PRESCRIPTION (82 QUESTIONS)
Question:
Which of the following is NOT recommended as an alternative treatment for bacterial
... [Show More] vaginosis?
Intramuscular ceftriaxone (Rocephin) Correct Clindamycin (Cleocin) vaginal cream Metronidazole (Flagyl) vaginal cream Tinidazole (Tindamax) orally
Explanation:
Intramuscular ceftriaxone (Rocephin) is not indicated in the treatment of bacterial vaginosis. Metronidazole (Flagyl) vaginal cream may be used if metronidazole oral is ineffective or not well tolerated. Alternative regimens include several tinidazole regimens or clindamycin (oral or intravaginal).
Question:
The recommended empiric treatment of pelvic inflammatory disease is: penicillin G benzathine (Bicillin) intramuscularly plus ceftriaxone (Rocephin)
intramuscularly.
azithromycin (Zithromax) orally plus ceftriaxone (Rocephin) intramuscularly. ceftriaxone (Rocephin) intramuscularly plus doxycycline (Vibramycin). Correct metronidazole (Flagyl) plus ofloxacin (Floxin).
Explanation:
The recommended empiric treatment for mild to moderate symptoms of pelvic inflammatory disease (PID) is ceftriaxone (Rocephin) 250 mg intramuscularly plus doxycycline (Vibramycin) 100 mg twice daily x 14 days with or without metronidazole (Flagyl) 500 mg PO twice daily x 14 days. All regimens used to treat PID should also be effective against Neisseria gonorrhoeae and Chlamydia trachomatis because negative endocervical screening for these organisms does not rule out upper-reproductive tract infection.
Question:
For the treatment of chlamydia, azithromycin (Zithromax) should be given: as one-time dose. Correct
daily for 3 days. daily for 5 days. daily for 7 days.
Explanation:
For the treatment of chlamydia, azithromycin (Zithromax) should be given as a single dose, 1 gram orally. Azithromycin (Zithromax) is classified as a macrolide. It is active against most isolates of Chlamydia trachomatis, Neisseria gonorrhoeae, and Streptococcus pneumoniae.
Question: [Show Less]